Community-Acquired Infections

• 

  Subject Areas on Research

  • A case-control study of community-associated Clostridium difficile infection: no role for proton pump inhibitors. 
  • A community approach to mortality prediction in sepsis via gene expression analysis. 
  • A comparison of HIV-positive patients with and without infective endocarditis: an echocardiographic study--the Emory Endocarditis Group experience. 
  • A cost-minimization analysis comparing azithromycin-based and levofloxacin-based protocols for the treatment of patients hospitalized with community-acquired pneumonia: results from the CAP-IN trial. 
  • A systematic review of clinical guidelines on the management of acute, community-acquired CNS infections. 
  • An international perspective on hospitalized patients with viral community-acquired pneumonia. 
  • Application of antimicrobial stewardship to optimise management of community acquired pneumonia. 
  • Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired Pneumonia. 
  • Assessment of Clostridium difficile-associated disease surveillance definitions, North Carolina, 2005. 
  • Associations between Community-Acquired Pneumonia and Proton Pump Inhibitors in the Laryngeal/Voice-Disordered Population. 
  • Associations between Community-Acquired Pneumonia and Proton Pump Inhibitors in the Laryngeal/Voice-Disordered Population. 
  • Atypical pathogens and challenges in community-acquired pneumonia. 
  • Bacterial etiology of community-acquired pneumonia in immunocompetent hospitalized patients and appropriateness of empirical treatment recommendations: an international point-prevalence study. 
  • Blood culture contamination with Enterococci and skin organisms: implications for surveillance definitions of primary bloodstream infections. 
  • Bloodstream infections in community hospitals in the 21st century: a multicenter cohort study. 
  • Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients. 
  • Ceftaroline fosamil for treatment of community-acquired pneumonia: findings from FOCUS 1 and 2 and potential role in therapy. 
  • Ceftaroline: clinical and microbiology experience with focus on methicillin-resistant Staphylococcus aureus after regulatory approval in the USA. 
  • Classification of community-acquired endocarditis due to coagulase-negative staphylococci. 
  • Clin-Star corner: What's new at the interface of geriatrics, infectious diseases, and antimicrobial stewardship. 
  • Clinical MRSA isolates from skin and soft tissue infections show increased in vitro production of phenol soluble modulins. 
  • Clinical practice. Acute infectious diarrhea. 
  • Community SARS-CoV-2 Surge and Within-School Transmission. 
  • Community and Close Contact Exposures Associated with COVID-19 Among Symptomatic Adults ≥18 Years in 11 Outpatient Health Care Facilities - United States, July 2020. 
  • Community respiratory viral infection in adult lung transplant recipients. 
  • Community-Acquired Pneumonia in Adults: Diagnosis and Management. 
  • Community-acquired MRSA infections in North Carolina children: prevalence, antibiotic sensitivities, and risk factors. 
  • Community-associated Clostridium difficile infection: experience of a veteran affairs medical center in southeastern USA. 
  • Community-associated methicillin-resistant Staphylococcus aureus necrotizing fasciitis in a neonate. 
  • Comparison of the Respiratory Resistomes and Microbiota in Children Receiving Short versus Standard Course Treatment for Community-Acquired Pneumonia. 
  • Contrasting methicillin-resistant Staphylococcus aureus colonization in Veterans Affairs and community nursing homes. 
  • Cryptococcal ventricular-peritoneal shunt infection: clinical and epidemiological evaluation of two closely associated cases. 
  • De-escalation therapy among bacteraemic patients with community-acquired pneumonia. 
  • Delays in appropriate antibiotic therapy for gram-negative bloodstream infections: a multicenter, community hospital study. 
  • Development of an Adult Physiologically Based Pharmacokinetic Model of Solithromycin in Plasma and Epithelial Lining Fluid. 
  • Effectiveness of antimicrobial guidelines for community-acquired pneumonia in children. 
  • Emergence of coagulase-negative staphylococci as a cause of native valve endocarditis. 
  • Emergence of extended-spectrum beta-lactamase-producing Escherichia coli in community hospitals throughout North Carolina: a harbinger of a wider problem in the United States? 
  • Epidemiologic Trends in Clostridioides difficile Infections in a Regional Community Hospital Network. 
  • Epidemiology of Coxiella burnetii infection in Africa: a OneHealth systematic review. 
  • Epidemiology of methicillin-resistant Staphylococcus aureus pneumonia in community hospitals. 
  • Epidemiology of methicillin-resistant Staphylococcus aureus. 
  • Evaluation of a rapid immunochromatographic test for detection of Streptococcus pneumoniae antigen in urine samples from adults with community-acquired pneumonia. 
  • Favorable impact of an infection control network on nosocomial infection rates in community hospitals. 
  • First reported case of infective endocarditis caused by community-acquired methicillin-resistant Staphylococcus aureus not associated with healthcare contact in Brazil. 
  • Fluoroquinolone resistance during 2000-2005: an observational study. 
  • Gastrointestinal Microbiome Disruption and Antibiotic-Associated Diarrhea in Children Receiving Antibiotic Therapy for Community-Acquired Pneumonia. 
  • Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study. 
  • Harmonisation in study design and outcomes in paediatric antibiotic clinical trials: a systematic review. 
  • Health care--associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. 
  • Health care--associated bloodstream infections. 
  • Health care-associated native valve endocarditis: importance of non-nosocomial acquisition. 
  • Hospital-Acquired Pressure Injury Development Among Surgical Critical Care Patients Admitted With Community-Acquired Pressure Injury: A Retrospective Cohort Study. 
  • Hospitalization for community-acquired, rotavirus-associated diarrhea: a prospective, longitudinal, population-based study during the seasonal outbreak. The Greater Toronto Area/Peel Region PRESI Study Group. Pediatric Rotavirus Epidemiology Study for Immunization. 
  • Identification of novel risk factors for community-acquired Clostridium difficile infection using spatial statistics and geographic information system analyses. 
  • Imaging of bacterial pulmonary infection in the immunocompetent patient. 
  • Impact of physician-assisted triage on timing of antibiotic delivery in patients admitted to the hospital with community-acquired pneumonia (CAP). 
  • Inadequate postgraduate training of skin and soft tissue infections in an era of community-associated methicillin-resistant Staphylococcus aureus. 
  • Incidence of and risk factors for community-associated Clostridium difficile infection: a nested case-control study. 
  • Increasing Incidence of Extended-Spectrum β-Lactamase-Producing Escherichia coli in Community Hospitals throughout the Southeastern United States. 
  • Individualizing duration of antibiotic therapy in community-acquired pneumonia. 
  • Infectious diarrhea in developed and developing countries. 
  • Infective endocarditis due to Staphylococcus aureus: 59 prospectively identified cases with follow-up. 
  • Inside-out: the changing epidemiology of methicillin-resistant Staphylococcus aureus. 
  • International prevalence and risk factors evaluation for drug-resistant Streptococcus pneumoniae pneumonia. 
  • Macrolides and Pediatric Community-Acquired Pneumonia-Time for a Paradigm Shift? 
  • Metabolomic derangements are associated with mortality in critically ill adult patients. 
  • Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research. 
  • Microfluidic platform versus conventional real-time polymerase chain reaction for the detection of Mycoplasma pneumoniae in respiratory specimens. 
  • Mycoplasma pneumoniae-associated diffuse alveolar haemorrhage: an atypical presentation of a prevalent pathogen. 
  • New rules for clinical trials of patients with acute bacterial skin and skin-structure infections: do not let the perfect be the enemy of the good. 
  • Non-HACEK gram-negative bacillus endocarditis. 
  • Outbreak of leptospirosis among triathlon participants and community residents in Springfield, Illinois, 1998. 
  • Paediatric bacterial meningitis in the USA: outcomes and healthcare resource utilization of nosocomial versus community-acquired infection. 
  • Part II. Analysis of data gaps pertaining to Shigella infections in low and medium human development index countries, 1984-2005. 
  • Pharmacokinetics and Safety of Ceftobiprole in Pediatric Patients. 
  • Platelet activation and pneumonia: is soluble p-selectin the right marker? 
  • Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients. 
  • Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community-acquired pneumonia. 
  • Procalcitonin: The Right Answer but to Which Question? 
  • Quinolone safety and efficacy more important than potency. 
  • Quinolones for community-acquired pneumonia. 
  • Radiographic Imaging of Community-Acquired Pneumonia: A Case-Based Review. 
  • Re: "Community-acquired pneumonia". 
  • Red eye after strabismus surgery: community-acquired MRSA periocular infection. 
  • Relationship between physician financial incentives and clinical pathway compliance: a cross-sectional study of 18 public hospitals in China. 
  • Risk factors for and estimated incidence of community-associated Clostridium difficile infection, North Carolina, USA. 
  • Serious infections among unselected patients with ST-elevation myocardial infarction treated with contemporary primary percutaneous coronary intervention. 
  • Short- vs Standard-Course Outpatient Antibiotic Therapy for Community-Acquired Pneumonia in Children: The SCOUT-CAP Randomized Clinical Trial. 
  • Solithromycin in Children and Adolescents With Community-acquired Bacterial Pneumonia. 
  • Staphylococcus aureus bacteremia at 5 US academic medical centers, 2008-2011: significant geographic variation in community-onset infections. 
  • Staphylococcus aureus endocarditis: The Grady Memorial Hospital Experience. 
  • Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. 
  • The Role of Stewardship in Addressing Antibacterial Resistance: Stewardship and Infection Control Committee of the Antibacterial Resistance Leadership Group. 
  • The clinical and molecular epidemiology of community- and healthcare-acquired rotavirus gastroenteritis. 
  • The epidemiology of chronic critical illness in the United States*. 
  • The evaluation of screening methods to identify medically unnecessary hospital stay for patients with pneumonia. 
  • The great imitator: Rocky Mountain spotted fever occurring after hospitalization for unrelated illnesses. 
  • The role of smears, cultures, and antibiotic sensitivity testing in the management of suspected infectious keratitis. 
  • Transfusion-transmitted and community-acquired babesiosis in New York, 2004 to 2015. 
  • Utility of a clinical risk factor scoring model in predicting infection with extended-spectrum β-lactamase-producing enterobacteriaceae on hospital admission. 
  • Zinc and the common cold: a meta-analysis revisited. 
  • [Etiologic characteristics of adult patients with community-acquired pneumonia in Beijing]. 
• 

  Keywords of People

  • Al-Hegelan, Mashael, Associate Professor of Medicine, Medicine, Pulmonary, Allergy, and Critical Care Medicine
  • Moehring, Rebekah, Associate Professor of Medicine, Medicine, Infectious Diseases